This article refers to:
Martinez-Garcia MA, Miravitlles M. Int J Chron Obstruct Pulmon Dis. 2017;12:1401–1411.
Page 1409, Disclosure, the text “The authors report no conflicts of interest in this work” should read “MM has received speaker fees from Boehringer Ingelheim, Chiesi, Cipla, Menarini, Rovi, Bial, CSL Behring, Grifols and Novartis; consultancy fees from Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Bial, Gebro Pharma, CSL Behring, Laboratories Esteve, Mereo BioPharma, Verona Pharma, pH Pharma, Novartis and Grifols; and research grants from GlaxoSmithKline and Grifols. MAM has received speaker fees from Chiesi, Grifols, Novartis, TEVA and Zambon; consultancy fees from Zambon and TEVA; and research grants from Zambon”.